Clinical Trial Update: Single Arm Study of Azacitidine and Venetoclax for Treatment of Newly Diagnosed Fit Acute Myeloid Leukemia Patients [NA]

View source ↗

Summary

A completed single-arm clinical trial evaluating the combination of azacitidine and venetoclax in newly diagnosed, fit patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Leukemia, Myeloid, Acute | NA | Status: COMPLETED